C. Moore

No ORCID on file · 16 papers in corpus · active 1995-2006

Study types

  • article 12
  • book-chapter 3
  • review 1

Condition tags

  • endometriosis 4
  • die_deep_infiltrating 3
  • dyspareunia 1
article 2006
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590500431482

High-dose dienogest (20 mg/day) was used for the treatment of endometriosis in women aged 18-52 years after laparoscopic and histological diagnosis of endometriosis and staging according to the revised American Fertility Society criteria. T…

article 2003
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters
·doi:10.1016/s0010-7824(03)00006-4
article 2002
Effect of dienogest-containing oral contraceptives on lipid metabolism
·doi:10.1016/s0010-7824(01)00310-9
article 2001
[Treatment of endometriosis with dienogest: preliminary report].
Ginekologia polska

AIM OF THE STUDY: Influence of two hormonal therapies (GnRH agonist--leuprolein acetate and a new progestin--dienogest) on symptoms of endometriosis in patients with different clinical grade of disease. MATERIAL AND METHODS: 34 women with e…

article 2000
A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system
·doi:10.3109/09513590009167655

The effects of two oral contraceptive combinations, dienogest 2.0 mg plus ethinyl estradiol 0.03 mg (Valette) and desogestrel 0.15 mg plus ethinyl estradiol 0.02 mg (Lovelle), on the human immune system were compared over one treatment cycl…

article 2000
Safety and efficacy profile of a high dose treatment of endometriosis with 20 mg dienogest per day
·doi:10.1016/s0020-7292(00)82572-2
article 1999
Clinical profile of Valette®
·doi:10.3109/13625189909085261

Studies have been undertaken to investigate the modulatory effects of a combination of 30 μg ethinylestradiol and 2.00 mg dienogest (Valette®) on ovarian function and on the hemostatic system. Modulation of ovarian function was investigated…

article 1999
Influence of Dienogest on Ovulation in Young Fertile Women
·doi:10.2165/00044011-199918040-00003
article 1999
The pharmacological profile of dienogest
·doi:10.3109/13625189909085259

Dienogest is the first non-alkylated 19-norprogestin on the market. This so-called hybrid progestin combines the typical qualities of the modern 19-norprogestins with those of natural progesterone and synthetic hydroxyprogesterone derivativ…

review 1998
Approaches to the replacement of ethinylestradiol by natural 17β-estradiol in combined oral contraceptives
·doi:10.1016/s0940-2993(98)80034-1
article 1997
Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system
·doi:10.1016/s0010-7824(97)00094-2
article 1997
[Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].

Antiandrogens or progestins with an antiandrogenic component usually have only a weak antigonadotropic activity. It is thus possible that the antiandrogenic effect on the cellular level is cancelled or at least reduced by an increased ovari…

article 1997
Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest
·doi:10.1016/s0010-7824(97)00123-6
book-chapter 1995
Der Einfluß von Dienogest auf die Ovulation junger Frauen und auf weitere ausgewählte endokrinologische Parameter
·doi:10.1515/9783112422168-017
book-chapter 1995
Vergleichende Untersuchungen zum Einfluß von Ethinylestradiol-haltigen Kontrazeptiva mit Dienogest- oder Levonorgestrel-Komponente auf die Cytochrom P-450-Funktion in vivo
·doi:10.1515/9783112422168-016

Vergleichende Untersuchungen zum Einfluß von Ethinylestradiol-haltigen Kontrazeptiva mit Dienogest- oder Levonorgestrel-Komponente auf die Cytochrom P-450-Funktion in vivo was published in Dienogest on page 149.

book-chapter 1995
Vergleichende Untersuchungen zum Einfluß von Ethinylestradiol-haltigen Kontrazeptiva mit Dienogest- oder Levonorgestrel-Komponente auf die Cytochrom P-450-Funktion in vivo
·doi:10.1515/9783110813210-016

Vergleichende Untersuchungen zum Einfluß von Ethinylestradiol-haltigen Kontrazeptiva mit Dienogest- oder Levonorgestrel-Komponente auf die Cytochrom P-450-Funktion in vivo was published in Dienogest on page 149.